Page 37 - TD-1-1
P. 37
Tumor Discovery The mechanism of cancer-related cognitive decline
35. Zhang Z, Yin J, Lu C, et al., 2019, Exosomal transfer of long https://doi.org/10.1200/jco.2018.78.6624
non-coding RNA SBF2-AS1 enhances chemoresistance 47. Collins B, MacKenzie J, Tasca GA, et al., 2013, Cognitive
to temozolomide in glioblastoma. J Exp Clin Cancer Res, effects of chemotherapy in breast cancer patients: A dose-
38(1): 166.
response study. Psychooncology, 22(7): 1517–1527.
https://doi.org/10.1186/s13046-019-1139-6
https://doi.org/10.1002/pon.3163
36. Koh YQ, Tan CJ, Toh YL, et al., 2020, Role of exosomes
in cancer-related cognitive impairment. Int J Mol Sci, 48. Mounier NM, Abdel-Maged AE, Wahdan SA, et al., 2020,
21(8):2755. Chemotherapy-induced cognitive impairment (CICI): An
overview of etiology and pathogenesis. Life Sci, 258: 118071.
https://doi.org/10.3390/ijms21082755
https://doi.org/10.1016/j.lfs.2020.118071
37. Sweeney MD, Zhao Z, Montagne A, et al., 2019, Blood-brain
barrier: from physiology to disease and back. Physiol Rev, 49. Bagnall-Moreau C, Chaudhry S, Salas-Ramirez K, et al., 2019,
99(1): 21–78. Chemotherapy-induced cognitive impairment is associated
with increased inflammation and oxidative damage in the
https://doi.org/10.1152/physrev.00050.2017 hippocampus. Mol Neurobiol, 56(10): 7159–7172.
38. Liebner S, Dijkhuizen RM, Reiss Y, et al., 2018, Functional https://doi.org/10.1007/s12035-019-1589-z
morphology of the blood-brain barrier in health and disease.
Acta Neuropathol, 135(3): 311–336. 50. Michalak S, Rybacka-Mossakowska J, Ambrosius W, et al.,
2016, The markers of glutamate metabolism in peripheral
https://doi.org/10.1007/s00401-018-1815-1 blood mononuclear cells and neurological complications in
39. Morad G, Carman CV, Hagedorn EJ, et al., 2019, Tumor- lung cancer patients. Dis Markers, 2016: 2895972.
derived extracellular vesicles breach the intact blood-brain https://doi.org/10.1155/2016/2895972
barrier via transcytosis. ACS Nano, 13(12): 13853–13865.
51. Gibson EM, Purger D, Mount CW, et al., 2014, Neuronal activity
https://doi.org/10.1021/acsnano.9b04397 promotes oligodendrogenesis and adaptive myelination in the
40. Sweeney MD, Sagare AP, Zlokovic BV, 2018, Blood- mammalian brain. Science, 344(6183): 1252304.
brain barrier breakdown in Alzheimer disease and other https://doi.org/10.1126/science.1252304
neurodegenerative disorder. Nat Rev Neurol, 14(3): 133–150.
52. Briones TL, Woods J, 2014, Dysregulation in myelination
https://doi.org/10.1038/nrneurol.2017.188 mediated by persistent neuroinflammation: Possible
41. Hanahan D, Weinberg RA, 2011, Hallmarks of cancer: The mechanisms in chemotherapy-related cognitive impairment.
next generation. Cell, 144(5): 646–674. Brain Behav Immun, 35: 23–32.
https://doi.org/10.1016/j.cell.2011.02.013 https://doi.org/10.1016/j.bbi.2013.07.175
42. Saharinen P, Eklund L, Alitalo K, 2017, Therapeutic 53. Berlin C, Lange K, Lekaye HC, et al., 2020, Long-term
targeting of the angiopoietin-TIE pathway. Nat Rev Drug clinically relevant rodent model of methotrexate-induced
Discov, 16(9): 635–661. cognitive impairment. Neuro Oncol, 22(8): 1126-1137.
43. Zajączkowska R, Kocot-Kępska M, Leppert W, et al., https://doi.org/10.1093/neuonc/noaa086
2019, Mechanisms of chemotherapy-induced peripheral 54. Sirichoat A, Krutsri S, Suwannakot K, et al., 2019, Melatonin
neuropathy. Int J Mol Sci, 20(6): 1451. protects against methotrexate-induced memory deficit and
https://doi.org/10.3390/ijms20061451 hippocampal neurogenesis impairment in a rat model.
Biochem Pharmacol, 163: 225–233.
44. Vitali M, Ripamonti CI, Roila F, et al., 2017. Cognitive
impairment and chemotherapy: A brief overview. Crit Rev 55. Sirichoat A, Suwannakot K, Chaisawang P, et al., 2020,
Oncol Hematol, 118: 7–14. Melatonin attenuates 5-fluorouracil-induced spatial
memory and hippocampal neurogenesis impairment in
https://doi.org/10.1016/j.critrevonc.2017.08.001
adult rats. Life Sci, 248: 117468.
45. de Ruiter MB, Reneman L, Boogerd W, et al., 2011, Cerebral https://doi.org/10.1016/j.lfs.2020.117468
hyporesponsiveness and cognitive impairment 10 years after
chemotherapy for breast cancer. Hum Brain Mapp, 32(8): 56. El-Agamy SE, Abdel-Aziz AK, Wahdan S, et al., 2018,
1206–1219. Astaxanthin ameliorates doxorubicin-induced cognitive
impairment (chemobrain) in experimental rat model: Impact
https://doi.org/10.1002/hbm.21102
on oxidative, inflammatory, and apoptotic machineries. Mol
46. Janelsins MC, Heckler CE, Peppone LJ, et al., 2018, Neurobiol, 55(7): 5727–5740.
Longitudinal trajectory and characterization of cancer-
related cognitive impairment in a nationwide cohort study. https://doi.org/10.1007/s12035-017-0797-7
J Clin Oncol, 36(32): JCO2018786624. 57. Keeney JT, Miriyala S, Noel T, et al., 2015, Superoxide
Volume 1 Issue 1 (2022) 9 https://doi.org/10.36922/td.v1i1.46

